Now Reading: Parliamentary Panel Seeks US Tariff Exemptions for Pharma and Smartphones
-
01
Parliamentary Panel Seeks US Tariff Exemptions for Pharma and Smartphones
Parliamentary Panel Seeks US Tariff Exemptions for Pharma and Smartphones
A Rajya Sabha commerce committee has urged the government to seek complete exemption for Indian pharmaceuticals, smartphones and critical minerals from any future US tariff increases under the proposed India-US Bilateral Trade…
The Story in Brief
A Rajya Sabha commerce committee has urged the government to seek complete exemption for Indian pharmaceuticals, smartphones and critical minerals from any future US tariff increases under the proposed India-US Bilateral Trade Agreement. The panel called for the pact to be concluded early to give exporters greater certainty while protecting India’s interests.
The committee also recommended a dedicated Directorate General of Foreign Trade watch desk to track US customs changes and alert exporters in real time. It sought a time-bound plan to reach the Mission 500 target of $500 billion in bilateral trade by 2030. The report said tariff uncertainty was hurting exporters’ price competitiveness and influencing US sourcing decisions.
The Indian Opinion
The loudest claims will likely present tariff exemptions as either an easy diplomatic win or proof that trade ties are failing. Neither follows from a committee recommendation. Exemptions must be negotiated, and exporters still need timely customs information and competitive costs. The useful test is whether the final pact protects these sectors and whether bilateral trade moves towards the $500 billion target by 2030.
Source: thehindubusinessline.com
This story was synthesised by AI from the source linked above.
